Cart summary

You have no items in your shopping cart.

Tegaserod maleate

SKU: orb1225822

Description

Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome.

Images & Validation

Key Properties

CAS Number189188-57-6
MW417.46
Purity>98% (HPLC)
FormulaC20H27N5O5
SMILESCCCCCN=C(N)NN/C=C/1\C=NC2=C1C=C(C=C2)OC.C(=C\C(=O)O)\C(=O)O
Target5-HT Receptor
SolubilityDMSO: 35mg/mL

Bioactivity

In Vivo
Animal model: C57BL/6 J mice were subcutaneously injected with B16F10 cells. Dosage: 5 mg/kg. Administration: Administered intraperitoneally (i.p.) daily for five consecutive days. Result: Treatment significantly decreased tumor growth and resulted in only slight decreases in weight following treatment. Animal model: Female C57BLKS/J db/db mice. Dosage: 0.1, 0.5, 1.0, 2.0 mg/kg. Administration: IP; 15 min prior to gastric loading. Result: Produced a dramatic decrease in the fraction of the meal remaining in the stomach for doses as low as 0.1 mg/kg (0.1 mg/kg). Accelerated gastric emptying, with a reduction of nearly 80% in the fraction remaining at 30 min (P < 0.0001) (0.1 mg/kg). Induced a significant decrease in the gastric emptying rate as the amount of the meal remaining at 30 min was significantly greater (2.0 mg/kg). Resulted in inhibition of tegaserod-induced increased gastric emptying (0.1 mg/kg).
In Vitro
Apoptosis Analysis Cell line: A375, RPMI-7951 (RPMI), SH4, B16F10, MeWo and MEL-JUSO. Concentration: 3, 5 μM. Incubation time: 24, 48, 72 h. Result: There was a significant time and dose-dependent increase in apoptosis in all cell lines. Western blot analysis. Cell line: RPMI, SH4 and B16F10 cells. Concentration: 3, 5 μM. Incubation time: 8 or 18 h. Result: Decreased phosphorylation of the kinase directly upstream of S6, p70 S6 at Thr421/Ser424.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

SDZ-HTF 919 | Zelnorm

Similar Products

  • Tegaserod maleate [orb3033171]

    >98%

    189188-57-6

    417.5

    C16H23N5O·C4H4O4

    50 mg, 10 mg
  • Tegaserod maleate [orb1308220]

    99.06% (May vary between batches)

    189188-57-6

    417.46

    C20H27N5O5

    10 mg, 50 mg, 100 mg, 200 mg, 1 ml x 10 mM (in DMSO), 25 mg, 500 mg
  • Tegaserod (maleate) [orb363707]

    >98%

    189188-57-6

    301.386722803116

    C16H23N5O

    100 mg, 250 mg, 1 g
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Tegaserod maleate (orb1225822)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

10 mg
$ 80.00
25 mg
$ 130.00
50 mg
$ 190.00
100 mg
$ 300.00
200 mg
$ 440.00
500 mg
$ 710.00